Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Cardiff and Vale University Health Board
2nd Floor, Woodland House, Maes-Y-Coed Road
Cardiff
CF14 4HH
UK
Contact person: Marisa Riley
Telephone: +44 2921501085
E-mail: marisa.riley2@wales.nhs.uk
NUTS: UKL22
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Vasectomy Services for Cardiff and Vale University Health Board
Reference number: CAV-CP-63085
II.1.2) Main CPV code
85121000
II.1.3) Type of contract
Services
II.1.4) Short description
CAVUHB is seeking a provider to deliver a high-quality vasectomy service across Cardiff and the Vale, primarily within a primary care setting. The service will include assessment, procedure, follow-up, and aftercare, and must be safe, accessible, and aligned with clinical standards, supporting timely patient access and integration with existing healthcare pathways.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
237 000.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
85120000
II.2.3) Place of performance
NUTS code:
UKL22
II.2.4) Description of the procurement
Cardiff and Vale University Health Board (CAVUHB) is seeking to commission a suitably qualified provider to deliver a comprehensive vasectomy service for eligible patients across Cardiff and the Vale of Glamorgan, primarily within a primary care setting. The service will provide safe, effective, and high-quality minor surgical procedures in line with relevant national clinical guidelines and standards.
The appointed provider will be responsible for delivering an end-to-end pathway, including patient assessment and counselling, procedure delivery, post-operative follow-up, and aftercare, ensuring appropriate clinical governance and patient safety throughout. The service must support timely and equitable access, patient choice, and a person-centred approach to care.
The provider will be required to work collaboratively with primary care and other relevant services to ensure effective referral pathways, communication, and continuity of care. The service must demonstrate robust clinical governance, maintain high standards of quality and patient safety, and ensure a consistent, patient-centred approach throughout the care pathway.
This is an intention to award under the competitive process.
This is an existing service with an existing provider.
The service is intended to be delivered between 10th August 2026 to 9th August 2027 with the option to extend for 12 months.
II.2.5) Award criteria
Quality criterion: Technical
/ Weighting: 70
Cost criterion: Commerical
/ Weighting: 30
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2026/S 000-046578
Section V: Award of contract
Contract No: CAV-CP-63085
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
27/07/2026
V.2.2) Information about tenders
Number of tenders received: 2
Number of tenders received from SMEs: 2
Number of tenders received from tenderers from EU Member States: 2
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 2
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Ashgrove Medical Group
Morgan Street
Pontypridd
CF372DR
UK
Telephone: +44 1443404444
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 237 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
This is a Provider Selection Regime Wales (PSR Wales) intention to award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 5th August 2026.. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR Wales.
Written representations by providers must be made to decision makers by E-mail:
Marisa Riley – marisa.riley2@wales.nhs.uk
Jane Boult – jane.boult@wales.nhs.uk
The award decision-makers comprised representatives from the Primary Care Clinical Board, supported by Procurement, the Assistant Director of Primary Care and Deputy Clinical Board Director, and the Clinical Director for Quality, Safety and Governance.
The evaluation panel confirmed that both bidders met all mandatory selection requirements and accepted the proposed contractual terms. Tender responses were assessed against the published award criteria of Commercial (30%), Technical Quality (55%) and Social Value (15%), reflecting the Health Board's commitment to securing a high-quality, patient-focused and outcomes-driven service.
Following evaluation, Ashgrove Medical Group achieved the highest overall score and was identified as offering the most economically advantageous tender. Whilst both bidders demonstrated the capability to deliver the service, Ashgrove Medical Group's submission achieved the highest combined score when all evaluation criteria and weightings were applied. The provider also submitted the most competitive commercial proposal, which contributed significantly to its overall ranking.
The evaluation panel concluded that Ashgrove Medical Group offered the best overall value for money and represented the optimum combination of quality and cost. The award decision was therefore supported by the evaluation outcomes and was reached transparently, fairly and in accordance with the published evaluation methodology.
No providers were excluded from the procurement process.
Potential conflicts of interest were identified within the original evaluation panel. To ensure the integrity, transparency and impartiality of the evaluation process, the panel membership was revised and the tender responses were assessed by an alternative evaluation panel with no identified conflicts of interest.
Information that has not been published and is withheld under regulation 23(1) due to commercial sensitivity
(WA Ref:168099)
VI.4) Procedures for review
VI.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Telephone: +44 2079477501
VI.5) Date of dispatch of this notice
28/07/2026